Tetrahydrobiopterin-dependent production of L-DOPA in genetically modified primary fibroblasts: Basic research of gene therapy for Parkinson's disease

Pteridines

Volumn 7, Issue 4, 1996, Pages 151-153

  Ishida, Akihiko ^a,b   Yamashiro, Katsumi ^a   Mukawa, Jiro ^a   Hasegawa, Mamoru ^b  

^a UNIVERSITY OF THE RYUKYUS SCHOOL OF MEDICINE   (Japan)

^b DNAVEC Research Inc   (Japan)

Author keywords

Gene therapy; L DOPA; Parkinson's disease; Tetrahydrobiopterin

Indexed keywords

BIOPTERIN; LEVODOPA; TETRAHYDROBIOPTERIN;

ANIMAL CELL; ARTICLE; CELL TRANSPLANTATION; CONTROLLED STUDY; GENE THERAPY; IMMUNOCYTOCHEMISTRY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SKIN FIBROBLAST;

EID: 0030450002     PISSN: 09334807     EISSN: 21954720     Source Type: Journal    
DOI: 10.1515/pteridines.1996.7.4.151     Document Type: Article

References (6)

1. Lopez-Lozano, JJ., Bravo, G. & Abascal, J. Grafting of perfused adrenalmedullary tissue into the caudate nucleus of patients with Parkinso's diseases. J Neurosurg 1991; 75: 234-243.
2. Martin WR, Perlmutter JS. Assessment of fetal tissue transplantation in Parkinson's diseases. Neurology 1994; 44: 1777-1780.
3. Ishida A, Yamashiro K, Mukawa J, Hasegawa M. Regulatin of L-DOPA production by genetically modified primary fibroblasts transfected with retrovirus vector system. Cell Transplantation 1995; in press.
4. Ishida A, Mukawa J, Yamashiro K, et al. Synthesis of L-DOPA by primary skin fibroblasts transfected with a fretrovirus vector containing human tyrosine hydroxylase cDNA. Ryukyu Med J 1994; 15: 37-39.
5. Ishida A, Mukawa J. L-DOPA production primary fibroblasts genetically modified with a retrovirus vector. Brain and Nerve (Tokyo) 1994; 47: 887-892.
6. Akagi, T, Nyunoya H, Shimotohno K. Murine retroviral vectors expressing the tax 1 gene of human T-cell leukemia virus type 1. Gene 1991; 106: 255-259.